Related Experiment Video
Updated: Jan 27, 2026

An In Vitro System to Study Tumor Dormancy and the Switch to Metastatic Growth
Published on: August 11, 2011
Limiting tumor seeding as a therapeutic approach for metastatic disease
Asurayya Worrede1, Olimpia Meucci1, Alessandro Fatatis2
1Department of Pharmacology and Physiology, Drexel University College of Medicine, 245 N. 15(th) Street, Philadelphia, PA, USA.
Abstract:
Here we propose that therapeutic targeting of circulating tumor cells (CTCs), which are widely understood to be the seeds of metastasis, would represent an effective strategy towards limiting numerical expansion of secondary lesions and containing overall tumor burden in cancer patients. However, the molecular mediators of tumor seeding have not been well characterized. This is in part due to the limited number of pre-clinical in vivo approaches that appropriately interrogate the mechanisms by which cancer cells home to arresting organs. It is critical that we continue to investigate the mediators of tumor seeding as it is evident that the ability of CTCs to colonize in distant sites is what drives disease progression even after the primary tumor has been ablated by local modalities. In addition to slowing disease progression, containing metastatic spread by impeding tumor cell seeding may also provide a clinical benefit by increasing the duration of the residence of CTCs in systemic circulation thereby increasing their exposure to pharmacological agents commonly used in the treatment of patients such as chemotherapy and immunotherapies. In this review we will examine the current state of knowledge about the mechanisms of tumor cells seeding as well as explore how targeting this stage of metastatic spreading may provide therapeutic benefit to patients with advanced disease.
Insights
Targeting circulating tumor cells (CTCs) can limit cancer metastasis and reduce tumor burden. Understanding the molecular mechanisms of tumor seeding is crucial for developing effective anti-metastatic therapies.
Area of Science:
- Oncology
- Cancer Metastasis Research
Background:
- Circulating tumor cells (CTCs) are recognized as the primary drivers of cancer metastasis.
- The molecular mechanisms governing how CTCs home to distant organs remain incompletely understood.
- Effective pre-clinical models are limited for studying CTC homing and colonization.
Purpose of the Study:
- To review the current understanding of tumor cell seeding mechanisms.
- To explore the therapeutic potential of targeting CTCs to impede metastatic spread.
- To highlight the benefits of targeting tumor seeding for improved patient outcomes.
Main Methods:
- This review synthesizes existing literature on tumor cell seeding.
- It examines pre-clinical and clinical studies investigating CTC behavior.
- The review discusses potential therapeutic strategies targeting metastasis.
Main Results:
- Tumor cell seeding is a critical step in metastatic progression, driving disease advancement.
- Targeting CTCs offers a potential strategy to control secondary lesion formation.
- Impeding tumor seeding may enhance the efficacy of systemic therapies like chemotherapy and immunotherapy.
Conclusions:
- Therapeutic targeting of circulating tumor cells presents a promising strategy to limit metastatic spread.
- Further research into the molecular mediators of tumor seeding is essential for clinical translation.
- Interdicting the seeding process could improve treatment efficacy and patient survival in advanced cancers.
Related Concept Videos
Limiting Reactant
Seed Structure and Early Development of the Sporophyte
The Number e as a Limit
Introduction to Seed Plants
Therapeutic Index
Central Limit Theorem
The sample size, n, that...

